Cargando...
Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
Background. Non-alcoholic fatty liver disease (NAFLD) is the leading chronic hepatic condition worldwide and new approaches to management and treatment are limited.Summary. L-ornithine L-aspartate (LOLA) has hepatoprotective properties in patients with fatty liver of diverse etiology and results of...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Russo |
| Publicado: |
Gastro LLC
2019-03-01
|
| Colección: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Materias: | |
| Acceso en línea: | https://www.gastro-j.ru/jour/article/view/322 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|